Log in to save to my catalogue

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2836878192

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Genetic analysis has shown the presence of activating
BRAF
mutations in 94% of papillary craniopharyngiomas. A phase 2 study showed partial response or better in 15 of 16 previously untreated patients.

Alternative Titles

Full title

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2836878192

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2836878192

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2213329

How to access this item